Full control, it doesnt drop or go up it gets “placed”Its been 3 months since Paradigm and their $4 SP target were handed 60 cent stock with 1/2 a freebie at 75. Everything is running like a finely tuned Swiss watch. The pieces of the puzzle continue to fit. We even have former board members killing it at TRIL as its moved from 30 cents to $22 in less than one year on some phase 2 spectralation. The canadian bio market is an intimate little group. Im curious to see how APLI rides the CV19 wave. IMHO, EDT will drive the Canadian CV19 excitement, our products were almost built to battle this scourge. Do stay tuned, it will pay to recognize the CONTROL
Best,
Gadge